The White House is reviewing a closely held CMS plan to launch innovation center demonstrations to lower drug prices. CMS also will powwow with drug makers Tuesday (Jan. 24) in a second meeting to discuss implementation of ground-breaking drug-pricing provisions in the Inflation Reduction Act, specifically recent inflation rebate guidance in relation to the 340B drug discount program, agency officials tell Inside Drug Pricing.